EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Targeting efferocytosis for tissue regeneration: From microenvironment reprogramming to clinical translation

Yunzhu Li, Peiyu Li, Jiayi Song, Xue Zhang, Haitao Xiao, Ru Wang, Zhenyu Duan, Kui Luo, Xuewen Xu

Theranostics · 08.01.2026 · 16 (7) · 3697-3734

DOI: 10.7150/thno.126081 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Theranostics, erschienen am 08.01.2026. Verfasst von Yunzhu Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Burn Surgery, Department of Radiology, Huaxi MR Research Center (HMRRC), Institution of Radiology and Medical Imaging, Reha…. Hauptthemen laut MEDLINE: Efferocytosis, Regeneration. Die Arbeit wurde bisher 23-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Efferocytosis, phagocytic clearance of apoptotic cells (ACs), is an essential biological process that resolves inflammation and regulates tissue regeneration in various organ systems. Through removal of apoptotic cell debris, efferocytosis attenuates secondary necrosis and dampens the release of damage-associated molecular patterns (DAMPs). More importantly, it can reprogram phagocytes towards a pro-reparative phenotype via the secretion of anti-inflammatory mediators, metabolic rewiring, and the production of growth factors. There are four closely regulated stages in the entire process: "find-me" signal-mediated phagocyte recruitment, recognition of ACs via "eat-me" signals, AC internalization via Rho GTPase-dependent actin remodeling, and phagolysosomal degradation of ACs by either canonical or light chain 3 (LC3)-associated phagocytosis (LAP). In a repair context, efferocytosis may refer to the clearance of dying cells during various tissue repair processes, such as wound healing, liver injury, myocardial infarction, intestinal damage, kidney injury and muscle injury. Efferocytosis regulates inflammation resolution, stem/progenitor cell activation, extracellular matrix remodeling, and angiogenesis to coordinate tissue repair. Chronic pathology (e.g., diabetic ulcers, fibrosis) induced by dysfunctional efferocytosis results from accumulation of non-phagocytosed ACs that maintain inflammation and impair regeneration. Therapeutic strategies targeting dysfunctional efferocytosis have been developed, encompassing active pharmaceutical ingredients, biologics, and biomaterials-assisted therapeutic modalities. Despite promising outcomes from preclinical studies, challenges still exist in the spatiotemporal control and clinical translation of these therapeutic strategies. Future research could focus on the multi-omics integration and smart biomaterial development to dynamically modulate efferocytosis during different disease phases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EfferocytosisRegenerationHumansAnimalsInflammationApoptosisPhagocytosis

Stichwörter der Autor:innen

biomaterialsefferocytosisinflammation resolutionmacrophagetissue regeneration

Autor:innen und Institutionen

  • Department of Plastic and Burn Surgery, Department of Radiology, Huaxi MR Research Center (HMRRC), Institution of Radiology and Medical Imaging, Rehabilitation Therapy, Institute of Breast Health Medicine, Frontiers Sci…
  • Psychoradiology Key Laboratory of Sichuan Province, Key Laboratory of Transplant Engineering and Immunology, NHC, and Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Chengdu 610041, China.

Zitieren

APA

Li, Y., Li, P., Song, J., Zhang, X., Xiao, H., Wang, R., Duan, Z., Luo, K., & Xu, X. (2026). Targeting efferocytosis for tissue regeneration: From microenvironment reprogramming to clinical translation. Theranostics, 16(7), 3697-3734. https://doi.org/10.7150/thno.126081

Vancouver

Li Y, Li P, Song J, Zhang X, Xiao H, Wang R, et al. Targeting efferocytosis for tissue regeneration: From microenvironment reprogramming to clinical translation. Theranostics. 2026;16(7):3697-3734. doi:10.7150/thno.126081

BibTeX
@article{Li2026,
  author = {Li, Yunzhu and Li, Peiyu and Song, Jiayi and Zhang, Xue and Xiao, Haitao and Wang, Ru and Duan, Zhenyu and Luo, Kui and Xu, Xuewen},
  title = {Targeting efferocytosis for tissue regeneration: From microenvironment reprogramming to clinical translation},
  journal = {Theranostics},
  year = {2026},
  volume = {16},
  number = {7},
  pages = {3697--3734},
  doi = {10.7150/thno.126081}
}
Kostenlos starten →